Correlation Between Isofol Medical and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Isofol Medical and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isofol Medical and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Isofol Medical AB and CellaVision AB, you can compare the effects of market volatilities on Isofol Medical and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isofol Medical with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isofol Medical and CellaVision.

Diversification Opportunities for Isofol Medical and CellaVision

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Isofol and CellaVision is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Isofol Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isofol Medical AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Isofol Medical i.e., Isofol Medical and CellaVision go up and down completely randomly.

Pair Corralation between Isofol Medical and CellaVision

Assuming the 90 days trading horizon Isofol Medical AB is expected to generate 2.36 times more return on investment than CellaVision. However, Isofol Medical is 2.36 times more volatile than CellaVision AB. It trades about -0.01 of its potential returns per unit of risk. CellaVision AB is currently generating about -0.06 per unit of risk. If you would invest  264.00  in Isofol Medical AB on November 2, 2024 and sell it today you would lose (52.00) from holding Isofol Medical AB or give up 19.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Isofol Medical AB  vs.  CellaVision AB

 Performance 
       Timeline  
Isofol Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
CellaVision AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, CellaVision is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Isofol Medical and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Isofol Medical and CellaVision

The main advantage of trading using opposite Isofol Medical and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isofol Medical position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Isofol Medical AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital